|
Re: Wow! Quite the read!
|
7
|
Resverlogix Corp.
|
May 29, 2021 06:28PM
|
|
Re: Wow! Quite the read!
|
5
|
Resverlogix Corp.
|
May 29, 2021 06:32PM
|
|
Re: Wow! Quite the read!
|
6
|
Resverlogix Corp.
|
May 29, 2021 06:35PM
|
|
Re: Wow! Quite the read!
|
5
|
Resverlogix Corp.
|
May 29, 2021 06:37PM
|
|
Re: Wow! Quite the read!
|
6
|
Resverlogix Corp.
|
May 30, 2021 06:01PM
|
|
Recent article on use of « time to benefit »
|
3
|
Resverlogix Corp.
|
Nov 03, 2019 04:51PM
|
|
Recent paper - T2D and CHF
|
4
|
Resverlogix Corp.
|
Jun 24, 2020 05:28PM
|
|
RVX by inhaler?
|
7
|
Resverlogix Corp.
|
Aug 04, 2021 05:51PM
|
|
RVX by inhaler?!!
|
3
|
Resverlogix Corp.
|
Aug 04, 2021 11:30PM
|
|
Secondary endpoints
|
8
|
Resverlogix Corp.
|
Oct 11, 2019 02:13PM
|
|
Secondary endpoints
|
3
|
Resverlogix Corp.
|
Oct 22, 2019 06:32PM
|
|
Statnews - report on Biogen from San Diego
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 06:57AM
|
|
Synairgen
|
5
|
Resverlogix Corp.
|
Jul 20, 2020 07:25AM
|
|
To good to be true?
|
2
|
Resverlogix Corp.
|
Oct 29, 2021 05:19PM
|
|
Trial delay
|
11
|
Resverlogix Corp.
|
May 03, 2021 06:00PM
|
|
Trial design issues
|
7
|
Resverlogix Corp.
|
May 09, 2021 06:06PM
|
|
Useful article on ACE2
|
5
|
Resverlogix Corp.
|
Mar 27, 2020 04:02PM
|
|
Useful review on epigenetics and CKD for the scientists
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 09:22AM
|
|
Webcast
|
4
|
Resverlogix Corp.
|
May 12, 2021 02:08PM
|
|
Youtube interview at AHA - Dr Ray
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 06:00PM
|
